The Role of Technology in Healthcare Post Pandemic – Case Study: EY Uses Fullerton Health Telemedicine Services to Deploy Healthcare for Staff

Share on facebook
Share on twitter
Share on linkedin

Health tech is at the forefront of the response to COVID-19. The pandemic has accelerated the digitalisation of business operations for the health care industry, paving the way for digital transformation to ensure continued access of care and information. Technology has been at the heart of Fullerton Health’s (FH) strategy for growth. The pandemic has facilitated the creation and adoption of telemedicine and allowed us to avail our primary care services as part of corporate health programme for companies.

Employers find themselves in the midst of very challenging times. One of the most pressing concerns is how to keep their people safe and healthy. The restrictive environment of COVID-19 has been the catalyst to rapid adoption of telemedicine for companies as part of their corporate health programme.

In April 2020, at the peak of the pandemic in Singapore, EY became one of the first clients to adopt FH’s telemedicine, which is fully integrated via its corporate application FHN3. In addition to its full suite of services, the app is customised to individual’s health benefits and offers the employees of EY cashless and convenient access to video consultations with FH doctors whom they are familiar with, in the comfort of their own home via the FHN3 app.

“The launch of our enhanced application integrated with telemedicine marks our continued efforts to transform care for our clients and patients. Leveraging technology enables us to deliver superior experience, efficiency and more cost-effective care, in keeping with our purpose of affordable and accessible care for all,” said Ho Kuen Loon, Group Chief Executive Officer, Fullerton Health.

EY recognises that integrating Fullerton Health’s telemedicine services with existing health care offerings brings greater convenience and ease of access to care for its employees in Singapore, particularly during the COVID-19 pandemic where safe distancing measures and telecommuting were in place.

Max Loh, Singapore and Brunei Managing Partner, Ernst & Young LLP said: “We introduced telemedicine by Fullerton Health during the circuit breaker period, which allows our people to seek medical treatment for common ailments from the safety of their homes. Ensuring that our people are engaged and supported to continue to be productive and well was highly important to us. The wellbeing and safety of our people has always been and continues to be our number one priority.”

The telemedicine platform allows users to schedule an appointment and actualise a consult without having to spend time travelling to a clinic and queuing to see a doctor. Patients who require medication can have it conveniently delivered to their doorstep. They can also easily access their medical history, prescription details, and documents such as electronic medical certificates (e-MCs) within the app.

Telemedicine, will be a core component of health technology. The integration of this application to the entire patient journey is key to the adoption. EY chose FH as its health care provider based on its breadth of network facilities and services as well as depth of integration within its digital applications. Technology is intrinsic to every aspect of our lives. For health care, it should be leveraged to bring about more convenience, cost savings and better health outcomes.